alexa Abstract | Is Diclofenac Still a Threat to Gyps Vulture? A Case From Eastern Nepal and Adjoining Areas in India

International Journal of Pure and Applied Zoology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), used among livestock have been found to have a detrimental effect on scavengers including Gyps vultures contributing to a dramatic decline of the population in the Indian subcontinent. In an attempt to assess the status of different NSAIDs including diclofenac use and trade, the current study was conducted in eastern part of Nepal and adjoining areas in India. Despite its ban in use and trade, diclofenac was found to be in use in veterinary practices and was illegally kept for sale. The finding warrants an immediate concern, monitoring, awareness, and actions to curb the use and trade of this environmental poison for the recovery and conservation of Gyps vultures.

To read the full article Peer-reviewed Article PDF image

Author(s): Rabindra Kumar Mandal and Kapil Kishor Khadka


NSAIDs, meloxicam, diclofenac, vulture, conservation, physiology, cell and molecular biology, genetics, biochemistry, biotechnology, bioinformatics, microbiology, immunology, parasitology

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version